Dr. Klein on Precision Medicine for Prostate Cancer

Eric Klein, MD
Published: Wednesday, Jul 12, 2017



Eric Klein, MD, professor of Surgery, Lerner College of Medicine, Cleveland Clinic, discusses precision medicine in patients with prostate cancer.

The prostate cancer field has entered the precision medicine era, explains Klein. There are now clinically significant tools in all the different spaces in prostate cancer, such as better screening and tests for the tumor.
 
SELECTED
LANGUAGE


Eric Klein, MD, professor of Surgery, Lerner College of Medicine, Cleveland Clinic, discusses precision medicine in patients with prostate cancer.

The prostate cancer field has entered the precision medicine era, explains Klein. There are now clinically significant tools in all the different spaces in prostate cancer, such as better screening and tests for the tumor.
 

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Oncology Briefings™: Current Perspectives on Preventing and Managing Tumor Lysis SyndromeJun 30, 20191.0
Community Practice Connections™: 2nd Annual International Congress on Oncology Pathology™Aug 31, 20191.5
Publication Bottom Border
Border Publication
x